Q2 2025 · 13F-HR
Rhenman & Partners Asset Management ABholdings as filed
Filed 2025-08-13 · accession 0001213900-25-075249
$791.0M
Reported value
90
Positions
2025-06-30
Period end
The Brief · Rhenman & Partners Asset Management AB · Q2 2025
AI · grounded in 13F
Rhenman & Partners Asset Management AB established a new position in LLY valued at $45.1M. The fund also initiated new stakes in BSX for $31.8M and VRTX for $27.4M. Additional new positions include GKOS, ISRG, and THC. The fund manages a total of 90 positions with $791M in assets under management.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 532457108 | LLY | LILLY ELI & CO | $45.1M | 5.70% | 57,870 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $31.8M | 4.02% | 296,000 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $27.4M | 3.46% | 61,455 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $24.3M | 3.07% | 235,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $24.1M | 3.05% | 44,350 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $24.0M | 3.04% | 136,429 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $24.0M | 3.03% | 121,452 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $20.4M | 2.58% | 295,362 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $20.3M | 2.57% | 27,717 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $18.8M | 2.37% | 149,217 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $18.6M | 2.36% | 168,150 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $18.6M | 2.35% | 350,000 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $18.0M | 2.28% | 1,287,284 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $17.7M | 2.23% | 175,435 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $17.4M | 2.20% | 44,650 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $16.7M | 2.11% | 136,400 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $16.7M | 2.11% | 51,197 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $15.6M | 1.98% | 179,500 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $14.8M | 1.87% | 49,375 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $14.5M | 1.84% | 27,700 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $14.5M | 1.83% | 46,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $13.9M | 1.76% | 159,500 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $12.9M | 1.63% | 69,375 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $12.6M | 1.59% | 66,500 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $12.4M | 1.57% | 344,000 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $12.1M | 1.53% | 170,000 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $11.6M | 1.46% | 109,030 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $11.4M | 1.44% | 29,778 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $10.9M | 1.38% | 190,000 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $10.6M | 1.34% | 32,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $10.5M | 1.33% | 197,600 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $10.1M | 1.27% | 106,500 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $9.7M | 1.23% | 57,500 | Common | SOLE |
| 91324P102 | UNH | UNITED HEALTH GROUP INC | $9.5M | 1.20% | 30,430 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $9.5M | 1.20% | 90,800 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $9.2M | 1.17% | 55,000 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $8.2M | 1.04% | 149,650 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $8.0M | 1.01% | 58,500 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $7.2M | 0.91% | 182,000 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $6.7M | 0.85% | 312,092 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $6.6M | 0.84% | 22,200 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $6.1M | 0.77% | 116,000 | Common | SOLE |
| H01301128 | ALC | ALCON AG | $6.0M | 0.76% | 68,000 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $5.6M | 0.71% | 565,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $5.5M | 0.70% | 21,500 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $5.4M | 0.68% | 99,757 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $5.4M | 0.68% | 574,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $5.1M | 0.64% | 123,315 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $4.7M | 0.60% | 1,250,763 | Common | SOLE |
| 03763A207 | ASTH | ASTRANA HEALTH INC | $4.7M | 0.60% | 190,000 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $4.7M | 0.60% | 26,000 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $4.5M | 0.58% | 11,500 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $4.5M | 0.57% | 11,140 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $4.4M | 0.56% | 67,250 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $4.3M | 0.54% | 55,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $4.1M | 0.52% | 115,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $4.0M | 0.51% | 52,500 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $4.0M | 0.50% | 30,500 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $3.8M | 0.48% | 35,870 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $3.4M | 0.44% | 104,250 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL INC | $3.4M | 0.43% | 93,100 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $3.3M | 0.42% | 65,755 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $2.8M | 0.35% | 135,100 | Common | SOLE |
| 750491102 | RDNT | RADNET INC | $2.6M | 0.33% | 46,000 | Common | SOLE |
| 92346J108 | VCEL | VERICEL CORP | $2.5M | 0.31% | 58,000 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $2.4M | 0.31% | 19,500 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $2.4M | 0.30% | 53,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $2.4M | 0.30% | 126,627 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $2.3M | 0.28% | 85,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $2.1M | 0.27% | 45,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $2.1M | 0.27% | 185,000 | Common | SOLE |
| 74276R102 | PRVA | PRIVIA HEALTH GROUP INC | $2.1M | 0.27% | 91,189 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $2.0M | 0.26% | 13,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $1.8M | 0.22% | 12,750 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $1.7M | 0.21% | 78,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $1.6M | 0.20% | 93,250 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $1.6M | 0.20% | 460,000 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $1.5M | 0.19% | 12,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY IN | $1.4M | 0.18% | 250,000 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $1.4M | 0.18% | 100,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $1.3M | 0.16% | 165,750 | Common | SOLE |
| 26622P107 | DOCS | DOXIMITY INC | $1.3M | 0.16% | 21,000 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $1.3M | 0.16% | 55,127 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.1M | 0.14% | 39,000 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $1.1M | 0.14% | 647,827 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $1.1M | 0.14% | 460,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $1.1M | 0.14% | 35,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $887,364 | 0.11% | 28,278 | Common | SOLE |
| 09073M104 | TECH | BIO-TECHNE CORP | $771,750 | 0.10% | 15,000 | Common | SOLE |
| 45782T105 | INMB | INMUNE BIO INC | $411,836 | 0.05% | 178,284 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.